Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Spectranetics Receives FDA Clearance to Market TURBO-Booster
July 22nd, 2007
Spectranetics Corporation (NASDAQ:SPNC) announced it has received clearance from the Food and Drug Administration (FDA) to market its TURBO-Booster(TM) product for the treatment of arterial stenoses and occlusions in the leg, which represents a broader indication for use as compared to current labeling of the existing peripheral laser catheters. The TURBO-Booster functions as a guiding catheter facilitating directed ablation of blockages in the main arteries at or above the knee. The TURBO-Booster combined with Turbo elite(TM) laser catheters allows for removal of large amounts of plaque material within the SFA and popliteal arteries. The CELLO trial, the study...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
